Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 134,754 shares at $7.01 ($948K) on 2024-07-15, disclosed to the SEC on 2024-07-16.
Open-market sale of $948k ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.07 | 50,000 | $354K | 37.3% |
| 2 | $7.01 | 42,377 | $297K | 31.3% |
| 3 | $7.01 | 42,377 | $297K | 31.3% |
| Total | $7.03 avg | 134,754 | $948K | 100% |
| Filing → |
| ELYM | SELL | 2024-07-17 | $357K | — | Filing → |
| ELYM | SELL | 2024-07-11 | $737K | — | Filing → |
| ELYM | SELL | 2024-07-09 | $174K | — | Filing → |